SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K, dated May 13, 2020, is a current report filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The filing serves to announce the Company's financial results for the three months ended March 31, 2020. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are detailed in this filing text. The document solely acts as a notification that the Q1 2020 results have been issued.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies within the main text. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Ra Medical Systems, Inc., not Catheter Precision, Inc.
- Review Exhibit 99.1 (Press Release dated May 13, 2020) for actual financial figures for the quarter ended March 31, 2020.
- Confirm the trading symbol RMED on the New York Stock Exchange.
- Note that the financial data in this specific 8-K text is not legally "filed" under Section 18 liabilities.